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Abstract
Improved lifestyle and increased interpersonal relationships have led older people to look for ways to improve their appearance and the aging signs of aging.
Objective: I studied a sterile and isotonic medical device based on hyaluronic acid in a variable solution between 1500Kdalton and 1800Kdalton in off label because 
it is dedicated to the use on mucous membranes at 0.12% concentration on sale since 2015.
Methods: Subjective and objective evaluations were performed in vivo on selected voluntary patients, after having obtained regular informed consent.
Results: In agreement with previous studies on formulations containing hyaluronic acid with medium and high molecular weight specifically studied for aesthetic 
medicine, the results obtained in vivo demonstrate the effectiveness of this medium-high molecular weight formulated product injected into the dermis in reducing 
skin wrinkles and in improving the signs of aging.
Introduction
The improvement of interpersonal relationships combined with 
the extension of life expectancy have led to a significant increase in the 
overall appearance of the face and body [1]. The increasing proportion 
of women and men interested in skin rejuvenation has created a huge 
demand for so-called anti-aging remedies to rejuvenate the photo-
aging skin or naturally aging in the shortest possible time. The signs 
of the relative skin damage associated with age, such as wrinkles, 
relaxation and irregular pigmentation, are in fact strongly influenced 
by environmental factors, in particular sun exposure during life [2]. 
The young fibroblasts first produce elastin then glycosaminoglycans 
and eventually undergo involution through the normal aging process 
for the induction of reactive oxygen species [2,3]. Furthermore, 
the induction of the common deletion in human skin fibroblasts is 
accompanied by a measurable decrease in oxygen consumption and an 
increase in metalloprotein-1. Many studies have shown, in fact, how 
the induction of matrix metalloproteinases plays a major role in the 
pathogenesis of photoaging [4,5]. As a consequence aged skin displays 
an array of fine, superficial facial lines that leads to the formation of 
deep creases over the forehead and between the eyebrows, periorbitally, 
and in the nasolabial folds (Photo1). During the past few years, many 
different techniques for rejuvenation have been proposed. The simplest 
procedures involve the use of hyaluronic acid in variable concentrations 
in order to have a rapid remodeling of wrinkles and improve the 
survival of fibroblasts through a suitable cross-talking with growth 
factors [6], the most complex ones involve the association of several 
active ingredients in order to activate also the cellular metabolism and 
the protection of the membranes [7,8].
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Hyaluronic acid is an important component of the extracellular 
matrix and helps to give elasticity to the skin. It has a key position in 
wound healing and tissue repair processes due to its ability to maintain 
a moist environment conducive to healing and stimulation of growth 
factors, cellular constituents and migration of various cells essential for 
healing [9]. New production of collagen and elastin appear to be induced 
by degradation of injected hyaluronic acid as a response of fibroblasts 
on the matrix [10] and its use is safe [11]. Its depletion contributes to 
the appearance of wrinkles and blemishes (Figure 1). Hyaluronic acid 
(HA) is a natural linear polysaccharide that has been widely used in the 
biomedical field as it is a biocompatible, biodegradable, non-toxic and 
non-immunogenic polymer with high water affinity [12].
The product used for this study is a medium-high molecular 
weight hyaluronic acid of 1500Kdalton and 1800Kdalton at 0.12% 
concentration. It has been specifically formulated and marketed 
by a pharmaceutical company for use on mucous membranes. The 
concentration is usually expressed in weight / volume and in this case 
means that by weight its concentration is 1.2mg / ml. Before using 
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activity on fibroblast through the different pharmacological activities 
at different levels, both cellular and matrix and would help the operator 
to obtain the best rejuvenation results from skin biostimulation. This 
hypothesis will be part of a further study
Injection technique: The contents of the ampules were injected 
directly into different skin areas of the 28 submissive women, mean age 
46.7 years. The puncture technique used was based on a single injection 
every 7 day for 4 weeks, followed by other injections for a further 2 
weeks for a 60-day personalized global treatment with a final control at 
day 90 (regression period).
The treatment used was based on the technique of mesotherapy, 
using 2.5 ml of solution and a 30 g needle positioned at 45 ° to the 
surface of the skin. The needle was inserted up to the medium subcutis, 
suction was performed to ensure that the tip was not inside a blood 
vessel and the injection was then started slowly when the needle was 
withdrawn. The injection speed was always lower than 0.3 ml / min. The 
firm massage, with the index finger inside the mouth and the thumb 
outside, was then used to remove any irregularities. The amount of 2.5 
ml is sufficient to treat the entire face. With each vial it was possible to 
treat two patients.
Control assessment and dermatological evaluation
Control visits and evaluations were undertaken on the first day 
(D1, baseline) and after 60 (D60) days of treatment, with a follow-
up visit at D90 (regression period). The individual signs of chrono 
or photo-aging symptoms of skin irritation and the degree of the 
obtained correction for each treatment and each area were evaluated 
objectively using a 0–10 visual analog scale with separate scores for 
each site of the face (0 = no correction; 5 = satisfactory correction; 10 
= total correction). The degree of satisfaction with the efficacy of the 
product was also obtained subjectively by asking the patients if there 
was any itching, stinging, or burning sensation. The different mean 
evaluations are reported in (Figure 1).
Subjects evaluation
After the first and second month of treatment, with a follow-up 
at the third month (regression period), the subjects evaluated their 
satisfaction or dissatisfaction by giving scores on firmness, softness, 
hydration, and wrinkle appearance, using a scale of 0–4 for each 
criterion (0 = unsatisfactory; 4 = satisfactory), as per Berardesca et al. 
[17] The obtained results are reported in (Figure 2).
the product, I compared it with others specifically formulated by a 
well-known cosmetic medicine company to evaluate the percentage 
of hyaluronic acid in them. I observed that in the formulations 
commercialized the percentage ranged from 0.01% to 1.5% and this has 
reassured me about the possibility of its use in mesotherapeutic anti-
aging treatments, albeit in off-label. Naturally, the product had to be 
safe, biocompatible and stable at the implant site, with possible minimal 
complications. The sterility and the isotonicity of the formulation 
pushed me to an off-label use as an adjuvant in anti-aging treatments in 
aesthetic medicine.
High molecular weight HA (HMWHA) is deposited in normal 
tissues during homeostasis and promotes their stability whereas low 
molecular weight HA fragments (LMWHA) may arise from enzymatic 
activities. The degradation of HMWHA to LMWHA fragments, 
often leads to the generation of biologically active oligosaccharides 
with different properties [13]. Native high molecular weight HA has 
structural properties whereas HA degradation products (oligomers) 
stimulate endothelial cell proliferation and migration. HA oligomers 
modulate inflammatory processes and promote neo-angiogenesis 
during the different steps of wound healing. HA mediates its biological 
effects through binding interactions with specific cell-associated 
receptors (CD44 and RHAMM) [14]. MW HA may promote the 
biosynthesis of growth factors such as FGF-2 and KGF [15].
Aim
The aim of the study was to evaluate the rejuvenation effects of a 
medium-high molecular weight sterile and apyrogenic hyaluronic acid 
used in off-label and injected into the dermis on subjects affected by 
chrono and photo-aging in order to allow the doctor to reevaluate his 
working methods.
Material and methods
Each 5 ml sterile ampoule contained 0.12% hyaluronic acid in 
physiological solution and water for injections. The study took place in 
vivo and the safety and efficacy of the product was established to reduce 
the overall appearance of thin and deep lines.
Patient enrollment
Before the study, each subject was informed about the purpose of 
the study, and their written informed consent was obtained according 
to the ethics of medical-device experimentation. No drugs or cosmetic 
procedures affecting the course of the antiaging treatment were allowed 
2 weeks prior to the study period.
All the 28 volunteer women (age range 40–55 years) between 
October 2017 and January 2018 attended the medical office. The only 
criterion for entry in the study was the presence of one or more signs of 
chrono or photoaging affecting the face, such as fine wrinkling around 
the eyes, crease lines around the mouth and cheeks, wrinkling and 
spots on the back of the hands, etc, corresponding to degrees 3–5 of the 
photodigital scale described by Larnier et al. [16]
In vivo studies
Patient enrollment: The possibility of having a single product 
composed of medium-high molecular weight hyaluronic acid can 
improve patient-medical compliance and for the personalization of 
the active ingredients to be associated. If the doctor then wanted to 
combine this composition with other active ingredients could exploit 
the pharmacological activity of hyaluronic acid with the metabolic 
Figure 1. Dermatological mean evaluation on signs of chrono or photo-ageing after 
injective treatment
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Results and discussion
The obtained results seem to be in line with our expectations in 
vivo evaluations on the efficacy of the treatment. Practically all the 
subjects treated during the 60-day period reported that they were 
satisfied with the general aspect of their skin, which appeared softer and 
more hydrated since the first month of treatment, as shown in (Figures 
3 and 4). In line with their self-evaluation, the appearance of the fine 
wrinkling was notably reduced and the consequent skin softness and 
firmness enhanced during the entire treatment period. This general 
amelioration remained during the regression period also, 30 days after 
the interruption of the treatment. As shown in (Figure 2), both fine 
wrinkling and crease lines were reduced soon after the first 15 days 
of treatment, so that the general appearance of the face was notably 
ameliorated during the regression period also.
Conclusion
This interesting general amelioration is shown in (Figure 2), where 
a reduction of fine lines is evident. The in vivo results are confirmed 
based on our findings, the jaluronic acid active ingredient used, seems 
to be useful in improving the activity of fillers, rendering it useful as 
an antiaging remedy for the aestethic medicine armamentarium. In 
conclusion, this simple and low-cost biostimulating medical device, can 
be used off-label, for wrinkle treatment and rejuvenating looks. I am 
continuing the research using this hyaluronic acid as a base for other 
active ingredients such as amino acids, vitamin C and vitamin D and 
antioxidant.
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